ArticleFrontiers in oncology2025

Clinical and molecular characteristics, therapeutic strategies, and prognosis of non-small cell lung cancer patients harboring primary and acquired BRAF mutations.

Xiangran Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.